Study identifies genetic variants that influence response to preterm birth treatment

A UC San Francisco-led study has for the first time identified genetic variants that predict whether patients will respond to treatment for preterm birth, a condition that affects one in 10 infants born in the United States.

Early-onset heart failure significantly elevates the risk of all-cause mortality

Announcing a new article publication for Cardiovascular Innovations and Applications journal. This study was aimed at investigating the correlations between heart failure onset age and

January 6, 2024

New cardiovascular risk model could greatly decrease use of statins and increase heart attacks, study warns

If millions of Americans no longer qualify for a statin or a blood pressure medication based on a new calculator updated to better predict their

July 29, 2024

Roivant discussing sale of its Pfizer-partnered UC drug to Roche for $7B, according to report

Roivant is in discussions with Roche to sell its experimental ulcerative colitis drug for several billion dollars, less than a year after acquiring the program

July 15, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.